In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor

Magdalena H. Menhofer(Ludwig-Maximilians-Universität München), Stefan Zahler(Hokkaido Pharmaceutical University)
Cardiovascular Research
September 19, 2014
10.1093/cvr/cvu210
Cited by 7

Related Papers

The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility
|PLoS ONE|2014|32
Disentangling cadherin-mediated cell-cell interactions in collective cancer cell migration
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2
A Novel Interaction of Slug (SNAI2) and Nuclear Actin
|Cells|2024|2
Cell based strain stiffening of a non-fibrous matrix as organizing principle for morphogenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0